Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.

HD iPSC Consortium.

Cell Stem Cell. 2012 Aug 3;11(2):264-78. doi: 10.1016/j.stem.2012.04.027. Epub 2012 Jun 28.

2.

Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.

Juopperi TA, Kim WR, Chiang CH, Yu H, Margolis RL, Ross CA, Ming GL, Song H.

Mol Brain. 2012 May 21;5:17. doi: 10.1186/1756-6606-5-17.

3.

Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.

An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, Melov S, Ellerby LM.

Cell Stem Cell. 2012 Aug 3;11(2):253-63. doi: 10.1016/j.stem.2012.04.026. Epub 2012 Jun 28.

4.

HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity.

Mattis VB, Tom C, Akimov S, Saeedian J, Østergaard ME, Southwell AL, Doty CN, Ornelas L, Sahabian A, Lenaeus L, Mandefro B, Sareen D, Arjomand J, Hayden MR, Ross CA, Svendsen CN.

Hum Mol Genet. 2015 Jun 1;24(11):3257-71. doi: 10.1093/hmg/ddv080. Epub 2015 Mar 3.

5.

Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.

Chae JI, Kim DW, Lee N, Jeon YJ, Jeon I, Kwon J, Kim J, Soh Y, Lee DS, Seo KS, Choi NJ, Park BC, Kang SH, Ryu J, Oh SH, Shin DA, Lee DR, Do JT, Park IH, Daley GQ, Song J.

Biochem J. 2012 Sep 15;446(3):359-71. doi: 10.1042/BJ20111495.

PMID:
22694310
6.

Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes.

Jacquet L, Neueder A, Földes G, Karagiannis P, Hobbs C, Jolinon N, Mioulane M, Sakai T, Harding SE, Ilic D.

PLoS One. 2015 May 20;10(5):e0126860. doi: 10.1371/journal.pone.0126860. eCollection 2015.

7.

Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.

Wegrzynowicz M, Bichell TJ, Soares BD, Loth MK, McGlothan JS, Mori S, Alikhan FS, Hua K, Coughlin JM, Holt HK, Jetter CS, Pomper MG, Osmand AP, Guilarte TR, Bowman AB.

J Huntingtons Dis. 2015;4(1):17-36.

8.

Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.

Reddy PH, Charles V, Williams M, Miller G, Whetsell WO Jr, Tagle DA.

Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45.

9.

Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.

Ishiguro H, Yamada K, Sawada H, Nishii K, Ichino N, Sawada M, Kurosawa Y, Matsushita N, Kobayashi K, Goto J, Hashida H, Masuda N, Kanazawa I, Nagatsu T.

J Neurosci Res. 2001 Aug 15;65(4):289-97.

PMID:
11494364
10.

A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.

Margolis RL, O'Hearn E, Rosenblatt A, Willour V, Holmes SE, Franz ML, Callahan C, Hwang HS, Troncoso JC, Ross CA.

Ann Neurol. 2001 Dec;50(6):373-80.

PMID:
11761463
11.

A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.

Margolis RL, O'Hearn E, Rosenblatt A, Willour V, Holmes SE, Franz ML, Callahan C, Hwang HS, Troncoso JC, Ross CA.

Ann Neurol. 2001 Sep;50(3):373-80. Corrected and republished in: Ann Neurol. 2001 Dec;50(6):373-80.

PMID:
11558794
12.

CAG/CTG repeat expansions at the Huntington's disease-like 2 locus are rare in Huntington's disease patients.

Stevanin G, Camuzat A, Holmes SE, Julien C, Sahloul R, Dodé C, Hahn-Barma V, Ross CA, Margolis RL, Durr A, Brice A.

Neurology. 2002 Mar 26;58(6):965-7.

PMID:
11914418
13.

Autopsy-proven Huntington's disease with 29 trinucleotide repeats.

Kenney C, Powell S, Jankovic J.

Mov Disord. 2007 Jan;22(1):127-30.

PMID:
17115386
14.

Huntington's disease as caused by 34 CAG repeats.

Andrich J, Arning L, Wieczorek S, Kraus PH, Gold R, Saft C.

Mov Disord. 2008 Apr 30;23(6):879-81. doi: 10.1002/mds.21958.

PMID:
18307262
15.

Derivation of Huntington's disease-affected human embryonic stem cell lines.

Bradley CK, Scott HA, Chami O, Peura TT, Dumevska B, Schmidt U, Stojanov T.

Stem Cells Dev. 2011 Mar;20(3):495-502. doi: 10.1089/scd.2010.0120. Epub 2010 Aug 31.

PMID:
20649476
16.

Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells.

Lorincz MT, Zawistowski VA.

Mol Cell Neurosci. 2009 Jan;40(1):1-13. doi: 10.1016/j.mcn.2008.06.004. Epub 2008 Jun 19.

17.

Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavage.

Möncke-Buchner E, Reich S, Mücke M, Reuter M, Messer W, Wanker EE, Krüger DH.

Nucleic Acids Res. 2002 Aug 15;30(16):e83.

18.

Verification of somatic CAG repeat expansion by pre-PCR fractionation.

Hunter JM, Crouse AB, Lesort M, Johnson GV, Detloff PJ.

J Neurosci Methods. 2005 May 15;144(1):11-7. Epub 2004 Nov 28.

PMID:
15848234
19.

RNA toxicity induced by expanded CAG repeats in Huntington's disease.

Martí E.

Brain Pathol. 2016 Nov;26(6):779-786. doi: 10.1111/bpa.12427. Review.

PMID:
27529325
20.

Huntington's Disease: Relationship Between Phenotype and Genotype.

Sun YM, Zhang YB, Wu ZY.

Mol Neurobiol. 2017 Jan;54(1):342-348. doi: 10.1007/s12035-015-9662-8. Epub 2016 Jan 7. Review.

PMID:
26742514

Supplemental Content

Support Center